Baptiste Villemagne

Ethionamide Boosters. 2. Combining Bioisosteric Replacement and Structure-Based Drug Design To Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors

Marion Flipo, Matthieu Desroses, Nathalie Lecat‐Guillet et al. · Journal of Medicinal Chemistry · 2011 · 70 citations · Full text

Intrinsic Antibacterial Activity of Nanoparticles Made of β-Cyclodextrins Potentiates Their Effect as Drug Nanocarriers against Tuberculosis

Arnaud Machelart, Giuseppina Salzano, Xue Li et al. · ACS Nano · 2019 · 65 citations · Full text

Nanoparticles, Pβcd Nanoparticles, Nanotherapeutics +17

Ligand Efficiency Driven Design of New Inhibitors of <i>Mycobacterium tuberculosis</i> Transcriptional Repressor EthR Using Fragment Growing, Merging, and Linking Approaches

Baptiste Villemagne, Marion Flipo, Nicolas Blondiaux et al. · Journal of Medicinal Chemistry · 2014 · 64 citations · Full text

Medicinal Chemistry, Drug Target, Biochemistry +15

Pyrrolomycins Are Potent Natural Protonophores

Katherine Valderrama, Elizabeth Pradel, Alexander M. Firsov et al. · Antimicrobial Agents and Chemotherapy · 2019 · 43 citations · Full text

Cyclodextrin-based nanocarriers containing a synergic drug combination: A potential formulation for pulmonary administration of antitubercular drugs

Giuseppina Salzano, Jitendra Wankar, Stefano Ottani et al. · International Journal of Pharmaceutics · 2017 · 36 citations

Nanomedicine, Polymer-drug Conjugate, Cyclodextrin Production +10